vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and WYNDHAM HOTELS & RESORTS, INC. (WH). Click either name above to swap in a different company.
WYNDHAM HOTELS & RESORTS, INC. is the larger business by last-quarter revenue ($334.0M vs $207.8M, roughly 1.6× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs -18.0%, a 75.3% gap on every dollar of revenue. WYNDHAM HOTELS & RESORTS, INC. produced more free cash flow last quarter ($168.0M vs $142.2M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Wyndham Hotels & Resorts, Inc., is an American hospitality company based in Parsippany, New Jersey, United States. It describes itself as the largest hotel franchisor in the world, with 9,100 locations.
IDYA vs WH — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $334.0M |
| Net Profit | $119.2M | $-60.0M |
| Gross Margin | — | — |
| Operating Margin | 52.2% | — |
| Net Margin | 57.4% | -18.0% |
| Revenue YoY | — | -76.3% |
| Net Profit YoY | 330.1% | -170.6% |
| EPS (diluted) | $1.33 | $-0.80 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $334.0M | ||
| Q4 25 | — | $334.0M | ||
| Q3 25 | $207.8M | $382.0M | ||
| Q2 25 | — | $397.0M | ||
| Q1 25 | — | $316.0M | ||
| Q4 24 | — | $336.0M | ||
| Q3 24 | $0 | $396.0M | ||
| Q2 24 | $0 | $367.0M |
| Q1 26 | — | $-60.0M | ||
| Q4 25 | — | $-60.0M | ||
| Q3 25 | $119.2M | $105.0M | ||
| Q2 25 | — | $87.0M | ||
| Q1 25 | — | $61.0M | ||
| Q4 24 | — | $85.0M | ||
| Q3 24 | $-51.8M | $102.0M | ||
| Q2 24 | $-52.8M | $86.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | -11.4% | ||
| Q3 25 | 52.2% | 46.6% | ||
| Q2 25 | — | 37.8% | ||
| Q1 25 | — | 35.4% | ||
| Q4 24 | — | 38.4% | ||
| Q3 24 | — | 43.2% | ||
| Q2 24 | — | 39.5% |
| Q1 26 | — | -18.0% | ||
| Q4 25 | — | -18.0% | ||
| Q3 25 | 57.4% | 27.5% | ||
| Q2 25 | — | 21.9% | ||
| Q1 25 | — | 19.3% | ||
| Q4 24 | — | 25.3% | ||
| Q3 24 | — | 25.8% | ||
| Q2 24 | — | 23.4% |
| Q1 26 | — | $-0.80 | ||
| Q4 25 | — | $-0.77 | ||
| Q3 25 | $1.33 | $1.36 | ||
| Q2 25 | — | $1.13 | ||
| Q1 25 | — | $0.78 | ||
| Q4 24 | — | $1.06 | ||
| Q3 24 | $-0.60 | $1.29 | ||
| Q2 24 | $-0.68 | $1.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $64.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $468.0M |
| Total Assets | $1.2B | $4.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $64.0M | ||
| Q4 25 | — | $64.0M | ||
| Q3 25 | $786.9M | $70.0M | ||
| Q2 25 | — | $50.0M | ||
| Q1 25 | — | $48.0M | ||
| Q4 24 | — | $103.0M | ||
| Q3 24 | $920.0M | $72.0M | ||
| Q2 24 | $701.7M | $70.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.5B | ||
| Q3 25 | — | $2.6B | ||
| Q2 25 | — | $2.5B | ||
| Q1 25 | — | $2.5B | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | — | $2.4B | ||
| Q2 24 | — | $2.4B |
| Q1 26 | — | $468.0M | ||
| Q4 25 | — | $468.0M | ||
| Q3 25 | $1.1B | $583.0M | ||
| Q2 25 | — | $570.0M | ||
| Q1 25 | — | $579.0M | ||
| Q4 24 | — | $650.0M | ||
| Q3 24 | $1.2B | $583.0M | ||
| Q2 24 | $931.7M | $623.0M |
| Q1 26 | — | $4.2B | ||
| Q4 25 | — | $4.2B | ||
| Q3 25 | $1.2B | $4.3B | ||
| Q2 25 | — | $4.3B | ||
| Q1 25 | — | $4.2B | ||
| Q4 24 | — | $4.2B | ||
| Q3 24 | $1.2B | $4.2B | ||
| Q2 24 | $973.7M | $4.2B |
| Q1 26 | — | — | ||
| Q4 25 | — | 5.37× | ||
| Q3 25 | — | 4.43× | ||
| Q2 25 | — | 4.44× | ||
| Q1 25 | — | 4.29× | ||
| Q4 24 | — | 3.72× | ||
| Q3 24 | — | 4.19× | ||
| Q2 24 | — | 3.83× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $367.0M |
| Free Cash FlowOCF − Capex | $142.2M | $168.0M |
| FCF MarginFCF / Revenue | 68.4% | 50.3% |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | 1.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $437.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $367.0M | ||
| Q4 25 | — | $152.0M | ||
| Q3 25 | $142.2M | $86.0M | ||
| Q2 25 | — | $70.0M | ||
| Q1 25 | — | $59.0M | ||
| Q4 24 | — | $134.0M | ||
| Q3 24 | $-49.2M | $79.0M | ||
| Q2 24 | $-32.9M | $1.0M |
| Q1 26 | — | $168.0M | ||
| Q4 25 | — | $136.0M | ||
| Q3 25 | $142.2M | $75.0M | ||
| Q2 25 | — | $58.0M | ||
| Q1 25 | — | $52.0M | ||
| Q4 24 | — | $109.0M | ||
| Q3 24 | $-49.7M | $71.0M | ||
| Q2 24 | $-33.9M | $-6.0M |
| Q1 26 | — | 50.3% | ||
| Q4 25 | — | 40.7% | ||
| Q3 25 | 68.4% | 19.6% | ||
| Q2 25 | — | 14.6% | ||
| Q1 25 | — | 16.5% | ||
| Q4 24 | — | 32.4% | ||
| Q3 24 | — | 17.9% | ||
| Q2 24 | — | -1.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.8% | ||
| Q3 25 | 0.0% | 2.9% | ||
| Q2 25 | — | 3.0% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 7.4% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | — | 1.9% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | 0.82× | ||
| Q2 25 | — | 0.80× | ||
| Q1 25 | — | 0.97× | ||
| Q4 24 | — | 1.58× | ||
| Q3 24 | — | 0.77× | ||
| Q2 24 | — | 0.01× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDYA
Segment breakdown not available.
WH
| Fee-related and other revenues | $334.0M | 100% |
| Management and other fees | $2.0M | 1% |
